Financing news kept flowing this week from New England startups developing software, medical device, drug, and cleantech products.
—Ziptr, a Burlington, MA-based maker of software focused on business privacy and compliance, pinned down $6.8 million in equity financing from 26 investors.
—Lumicell Diagnostics, a portfolio company of Waltham, MA-based Kodiak Venture Partners that’s developing a cancer diagnostic device, added $2.7 million in equity-based funding.
—Bedford, MA-based Hologic (NASDAQ: [[ticker:HOLX]]), a developer of medical imaging and diagnostic devices, paid $135 million to acquire Chinese medical products distributor TCT International, which distributes Hologic’s ThinPrep Pap Test.
—General Compression, a Newton, MA-based energy storage technology company, raised a $20.4 million equity financing round from four investors. Its previous backers include Duke Energy, U.S. Renewables Group, and Northwater Intellectual Property Fund.
—Constellation Pharmaceuticals of Cambridge, MA, added another $15 million in Series B extensions from existing investors, including Third Rock Ventures, The Column Group, Venrock Associates, SR One, and Altitude Life Science Ventures. That brings the round to $37 million for Constellation, a developer of drugs for treating cancer, inflammatory and immunologic disorders, and other diseases.
—Concord, MA-based PolyRemedy nabbed $20 million in Series C financing to put towards commercializing its customized wound-healing system. New investor Delphi Ventures led the round, which also included previous PolyRemedy investors MedVenture Associates, Advanced Technology Ventures, and Flybridge Capital Partners. The money will go towards app development, manufacturing, and sales and marketing.
